ArticleIranian journal of parasitology
In Silico Characterization and Epitope Mapping of
Article in Iranian journal of parasitology. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: A neglected zoonosis, cystic echinococcosis (CE) is the most common diseas in the developing nations worldwide. Vaccination is helpful in preventing the disease. Predicting main biochemical properties of the Methods: This study was done in Neyshabur University of Medical Sciences, Neyshabur, Iran. Predictions about transmembrane domain, subcellular localization, post-translational modification (PTM) sites, physico-chemical, antigenic, and allergenic profiles, secondary and 3D structure, tertiary model refinement, and validations were done using online servers. Results: The cytoplasmic 79.05 kDa protein was non-allergenic, hydrophilic (GRAVY: -0.490), stable (instability: 39.30), with improved thermotolerance (aliphatic: 80.07) and 122 post-translational modification sites. The secondary structure mostly included helices and extended strands. The 3D model was generated using Robetta server (confidence: 0.59) and was refined and validated subsequently. Shared B-cell epitopes were discovered using ElliPro, ABCpred and SVMTriP servers with antigenicity, allergenicity, and solubility screening. Moreover, multiple human and mouse MHC-binding epitopes were predicted and screened in Conclusion: This work offers a foundation for further investigation regarding designing an effective vaccination against CE. Further empirical research using examined protein alone or in conjunction with other antigens/epitopes is needed in the future.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.